5-(Pyridin-2-yl)-1,3-thiazol-2-amine, 98%, 250mg

(R)-2-Amino-3-(prop-2-yn-1-ylthio)propanoic acid, 95.0%, 25g

(S)-1-tert-Butyl 2-ethyl 4-oxopiperidine-1,2-dicarboxylate, 95.0%, 10g

1,2,3,4-Tetrahydroacridin-9-amine, 95.0%, 5g

Methyl 4-Aminocyclohexanecarboxylate Hydrochloride (cis- and trans- mixture)>98.0%(N)(T)5g

2-(1H-Indol-3-yl)-2-methylpropan-1-amine hydrochloride, 95.0%, 100mg

6-Acetylpyridazin-3(2H)-one, 95.0%, 1g

5-cyclohexyl-4-nitro-1H-pyrazole, 98%, 1g

1-Bromo-3-fluoro-2-nitrobenzene, 95.0%, 5g

9,9'-Bianthracene, 95.0%, 25g

2-((2,3,6,7-tetrahydro-1H,5H-pyrido[3,2,1-ij]quinolin-9-yl)methylene)malononitrile, 95%, 500mg

1,3-Dimethyl-1,3-diphenylurea, 95.0%, 10g

2-Allyl-1-[6-(1-hydroxy-1-methylethyl)pyridin-2-yl]-6-[[4-(4-methylpiperazin-1-yl)phenyl]amino]-1,2-dihydro-3H-pyrazolo[3,4-d]pyrimidin-3-one, 98%, 250mg